EU and US could reach trade deal this weekend - Reuters
Investing.com - Enovix (NASDAQ: ENVX) reported fourth quarter EPS of $-0.11, $0.08 better than the analyst estimate of $-0.19. Revenue for the quarter came in at $9.72M versus the consensus estimate of $8.66M.
Guidance
Enovix sees Q1 2025 EPS of $-0.15 versus the analyst consensus of $-0.17.
Enovix sees Q1 2025 revenue of $3.50M-$5.50M versus the analyst consensus of $6.21M.
Enovix’s stock price closed at $11.19. It is up 18.66% in the last 3 months and down -5.01% in the last 12 months.
Enovix saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Enovix’s stock price’s past reactions to earnings here.
According to InvestingPro, Enovix’s Financial Health score is "weak performance".
Check out Enovix’s recent earnings performance, and Enovix’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar